1
|
Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial. Trials 2022; 23:876. [PMID: 36242060 PMCID: PMC9569116 DOI: 10.1186/s13063-022-06826-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 10/05/2022] [Indexed: 12/04/2022] Open
Abstract
Background This study is in regard to the comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from small cell lung cancer (SCLC). Therapeutically, they have notably varying dose distributions. Based on theoretical and model studies, it has long been speculated that these modes may result in different prognostic outcomes. We aim to assess the efficacy of tomotherapy in the treatment of SCLC brain metastases while protecting the key functional area, the hippocampus, and minimizing any neurocognitive impairments incurred by radiation. Methods This is a randomized, controlled, prospective study including 102 SCLC patients with brain metastases randomized (1:1) to the experimental (whole brain radiation therapy for synchronous brain metastases with irradiation to protect the hippocampus) or control (whole brain radiotherapy for sequential brain metastases to boost irradiation) group. The sample size is calculated through a single-sided test; 102 participants will be required for the main results to have statistical and clinical significance. We aim to provide clinical trial data support for better prognostic treatment options in patients with SCLC and brain metastases. The clinical trial data include both the primary and secondary outcomes; the primary outcome is the intracranial progression-free survival time after the new technology application. The secondary study outcomes include the assessment of neurological function, the quality of life, and the overall survival rate. Follow-up consultations will be conducted every 2 months. After the final patient completes follow-up, the Statistical Product and Service Solutions software will be used for scientific and rigorous data analysis. Version 1.0 of the protocol was implemented on January 1, 2021; the recruitment process for this clinical trial commenced on April 1, 2021, and will end on March 31, 2024. Discussion The study will provide high-quality clinical evidence to support the efficacy and safety of whole brain radiation therapy for synchronous brain metastases with dose irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases with push volume irradiation for the treatment of patients who have lung cancer as well as brain metastases. This has not been previously reported. Trial registration This trial is registered with the Chinese Clinical Trial Registry (ChiCTR1900027539; November 17, 2019) (URL: https://www.chictr.org.cn/hvshowproject.aspx?id=20515).
Collapse
|
2
|
Li D, Wang D, Feng S, Chen Q, Sheng X, Jia J, Yan X, Zhu J, Yin Y. Comparing dosimetric and cancer control outcomes after intensity‑modulated radiation therapy and tomotherapy for advanced cervical cancer. Oncol Lett 2022; 24:239. [PMID: 35720507 PMCID: PMC9185149 DOI: 10.3892/ol.2022.13359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2022] [Accepted: 04/11/2022] [Indexed: 11/14/2022] Open
Abstract
Concurrent chemoradiation therapy (CCRT) is the standard treatment for locally advanced cervical cancer. The present study aimed to compare the therapeutic responses, toxicities and dosimetric parameters between intensity-modulated radiation therapy (IMRT) and tomotherapy (TOMO) in patients with advanced cervical cancer. This retrospective study included 310 patients with stage IIB-IIIB cervical cancer who underwent CCRT, with 155 patients in each group. Intracavitary brachytherapy was performed after a course of external beam radiation therapy (EBRT), or in the last week of pelvic EBRT. The treatment planning aim at point A (defined as a reference location 2 cm above the vaginal fornix and 2 cm beside the mid axis of the uterus) was >85 Gy in an equivalent dose at 2 Gy. There was no statistical difference with regard to clinicopathological characteristics between the two groups (P>0.05). Improved dose conformity and dose homogeneity (P<0.05) were observed in TOMO planning. TOMO provided more efficacious critical organ sparing than IMRT when assessing the percentage of normal tissue receiving at least 20 Gy (V20) for the bladder, the percentage of normal tissue receiving at least 40 Gy (V40) for the femoral head, and the V40 and V20 for the rectum (P<0.05). TOMO demonstrated a greater ability to protect the ovary (P<0.05). The acute radiation toxicity of proctitis and leukopenia were significantly lower in the TOMO group (P<0.05). The chronic radiation toxicity of radiation enterocolitis and cystitis was lower in the TOMO group (P<0.05). Thus, TOMO provided better critical organ sparing than IMRT. The radiation toxicities were acceptable. Therefore, TOMO appears to be a good option for the treatment of stage IIB-IIIB cervical cancer.
Collapse
Affiliation(s)
- Dapeng Li
- Department of Gynecological Oncology, Shandong University Cancer Center, Jinan, Shandong 250117, P.R. China
| | - Dandan Wang
- Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China
| | - Shuai Feng
- Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China
| | - Quancai Chen
- Department of Gynecology and Obstetrics, Wulian Maternal and Child Care Service Center, Rizhao, Shandong 262300, P.R. China
| | - Xiugui Sheng
- Department of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong 518116, P.R. China
| | - Jue Jia
- Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China
| | - Xiaohui Yan
- Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China
| | - Jian Zhu
- Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R. China
| | - Yueju Yin
- Department of Gynecological Oncology, Shandong University Cancer Center, Jinan, Shandong 250117, P.R. China
| |
Collapse
|
3
|
Lu S, Fan H, Hu X, Li X, Kuang Y, Yu D, Yang S. Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma. Front Oncol 2021; 11:764946. [PMID: 34804969 PMCID: PMC8602559 DOI: 10.3389/fonc.2021.764946] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Accepted: 10/18/2021] [Indexed: 01/12/2023] Open
Abstract
OBJECTIVE To compare the dosimetric parameters of different radiotherapy plans [helical tomotherapy (HT), volume-modulated arc therapy (VMAT), and fixed-field intensity-modulated radiation therapy (FF-IMRT)] for locally advanced nasopharyngeal carcinoma (NPC). METHODS A total of 15 patients with locally advanced NPC were chosen for this retrospective analysis and replanned for HT, VMAT, and FF-IMRT. The prescribed planning target volume (PTV) dose for the primary tumor and metastatic lymph nodes was 70 Gy (2.12 Gy/fraction, delivered over 33 fractions). The prescribed PTV dose for the high-risk subclinical region was 59.4 Gy (1.8 Gy/fraction, delivered over 33 fractions). The dosimetric parameters of the PTV and organs at risk (OARs) and the efficiency of radiation delivery were assessed and compared using the paired-samples t-test. RESULTS Compared with VMAT and FF-IMRT plans, HT plans significantly improved the mean conformity index (CI) and homogeneity index (HI). The HT plans reduced the maximum doses delivered to OARs, such as the brainstem, spinal cord, and optic nerves, and significantly reduced the volume delivered to the high-dose region, especially when examining the V 30 value of the parotid glands. However, VMAT reduced the treatment time and improved the efficiency of radiation delivery compared with HT. CONCLUSIONS For locally advanced NPC, the results showed that HT and VMAT possessed better target homogeneity and conformity, reducing the dose delivered to OARs compared with conventional FF-IMRT, with HT achieving the best effect. Among the techniques studied, VMAT had the shortest radiation delivery time. The results of this study can provide guidance for the selection of appropriate radiation technologies used to treat patients with locally advanced NPC who are undergoing concurrent chemoradiotherapy.
Collapse
Affiliation(s)
- Shan Lu
- Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China
| | - Huiqi Fan
- Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China
| | - Xueyuan Hu
- Department of Radiation Physics, Harbin Medical University Cancer Hospital, Harbin, China
| | - Xin Li
- Department of Radiation Physics, Harbin Medical University Cancer Hospital, Harbin, China
| | - Yingying Kuang
- Department of Head and Neck Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China
| | - Deyang Yu
- Department of Radiation Physics, Harbin Medical University Cancer Hospital, Harbin, China
| | - Shanshan Yang
- Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China
| |
Collapse
|
4
|
Kodama T, Saito Y, Hatanaka S, Hariu M, Shimbo M, Takahashi T. Commissioning of the Mobius3D independent dose verification system for TomoTherapy. J Appl Clin Med Phys 2019; 20:12-20. [PMID: 30920130 PMCID: PMC6523001 DOI: 10.1002/acm2.12572] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2018] [Revised: 01/15/2019] [Accepted: 03/05/2019] [Indexed: 11/28/2022] Open
Abstract
In radiation therapy, a secondary independent dose verification is an important component of a quality control system. Mobius3D calculates three‐dimensional (3D) patient dose using reference beam data and a collapsed cone convolution algorithm and analyzes dose‐volume histogram automatically. There are currently no published data on commissioning and determining tolerance levels of Mobius3D for TomoTherapy. To verify the calculation accuracy and adjust the parameters of this system, we compared the measured dose using an ion chamber and film in a phantom with the dose calculated using Mobius3D for nine helical intensity‐modulated radiation therapy plans, each with three nominal field widths. We also compared 126 treatment plans used in our institution to treat prostate, head‐and‐neck, and esophagus tumors based on dose calculations by treatment planning system for given dose indices and 3D gamma passing rates with those produced by Mobius3D. On the basis of these results, we showed that the action and tolerance levels at the average dose for the planning target volume (PTV) at each treatment site are at μ ± 2σ and μ ± 3σ, respectively. After adjusting parameters, the dose difference ratio on average was −0.2 ± 0.6% using ion chamber and gamma passing rate with the criteria of 3% and 3 mm on average was 98.8 ± 1.4% using film. We also established action and tolerance levels for the PTV at the prostate, head‐and‐neck, esophagus, and for the organ at risk at all treatment sites. Mobius3D calculations thus provide an accurate secondary dose verification system that can be commissioned easily and immediately after installation. Before clinical use, the Mobius3D system needs to be commissioned using the treatment plans for patients treated in each institution to determine the calculational accuracy and establish tolerances for each treatment site and dose index.
Collapse
Affiliation(s)
- Takumi Kodama
- Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.,Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
| | - Yoshihiro Saito
- Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan
| | - Shogo Hatanaka
- Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
| | - Masatsugu Hariu
- Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
| | - Munefumi Shimbo
- Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
| | - Takeo Takahashi
- Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
| |
Collapse
|
5
|
Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2018; 24:301-307. [DOI: 10.1016/j.bbmt.2017.09.019] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Accepted: 09/30/2017] [Indexed: 12/16/2022]
|
6
|
Xu Y, Deng W, Yang S, Li P, Kong Y, Tian Y, Liao Z, Chen M. Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer. Sci Rep 2017; 7:14863. [PMID: 29093491 PMCID: PMC5665865 DOI: 10.1038/s41598-017-14629-w] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Accepted: 10/10/2017] [Indexed: 12/25/2022] Open
Abstract
The study aimed to compare the dosimetric parameters to target dose coverage and the critical structures in the treatment planning of helical tomotherapy (TOMO), volumetric-modulated arc therapy (VMAT), and fixed-field intensity-modulated radiotherapy (IMRT) for NSCLC delivering conventionally fractionated radiotherapy. Thirty patients with pathologically confirmed NSCLC were included. Three radiation treatment plans were designed for each patient. All patients received the uniform prescription dose of 60 Gy to the planning target volume. The conformity index (CI), heterogeneity index (HI), and parameters of critical structures were calculated. A significantly superior mean CI was observed in VMAT than in TOMO or IMRT (P = 0.013, 0.001). Mean HI was also better using VAMT or IMRT than TOMO (P = 0.002, 0.003). Mean lung V20 and V30 were significantly reduced by TOMO compared to IMRT (P = 0.019, 0.029). The heart was spared by IMRT compared to TOMO in terms of mean heart dose, V5, V10, and V20 (P < 0.05). In larger tumor, VMAT provided the optimal dose distribution and sparing to heart. Compared to TOMO and IMRT, VMAT achieved better target dose distribution and similar sparing of critical structures. VMAT seemed to be the optimal technique for NSCLC.
Collapse
Affiliation(s)
- Yujin Xu
- Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.,Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - Weiye Deng
- Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, USA
| | - Shuangyan Yang
- Department of Radiation Physics, Zhejiang Cancer Hospital, Hangzhou, China
| | - Pu Li
- Department of Radiation Physics, Zhejiang Cancer Hospital, Hangzhou, China
| | - Yue Kong
- Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - Ye Tian
- Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China
| | - Zhongxing Liao
- Department of Radiation Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, USA
| | - Ming Chen
- Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China. .,Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
| |
Collapse
|
7
|
Binny D, Lancaster CM, Trapp JV, Crowe SB. Statistical process control and verifying positional accuracy of a cobra motion couch using step-wedge quality assurance tool. J Appl Clin Med Phys 2017; 18:70-79. [PMID: 28730740 PMCID: PMC5874965 DOI: 10.1002/acm2.12136] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2017] [Revised: 05/21/2017] [Accepted: 05/30/2017] [Indexed: 11/21/2022] Open
Abstract
This study utilizes process control techniques to identify action limits for TomoTherapy couch positioning quality assurance tests. A test was introduced to monitor accuracy of the applied couch offset detection in the TomoTherapy Hi‐Art treatment system using the TQA “Step‐Wedge Helical” module and MVCT detector. Individual X‐charts, process capability (cp), probability (P), and acceptability (cpk) indices were used to monitor a 4‐year couch IEC offset data to detect systematic and random errors in the couch positional accuracy for different action levels. Process capability tests were also performed on the retrospective data to define tolerances based on user‐specified levels. A second study was carried out whereby physical couch offsets were applied using the TQA module and the MVCT detector was used to detect the observed variations. Random and systematic variations were observed for the SPC‐based upper and lower control limits, and investigations were carried out to maintain the ongoing stability of the process for a 4‐year and a three‐monthly period. Local trend analysis showed mean variations up to ±0.5 mm in the three‐monthly analysis period for all IEC offset measurements. Variations were also observed in the detected versus applied offsets using the MVCT detector in the second study largely in the vertical direction, and actions were taken to remediate this error. Based on the results, it was recommended that imaging shifts in each coordinate direction be only applied after assessing the machine for applied versus detected test results using the step helical module. User‐specified tolerance levels of at least ±2 mm were recommended for a test frequency of once every 3 months to improve couch positional accuracy. SPC enables detection of systematic variations prior to reaching machine tolerance levels. Couch encoding system recalibrations reduced variations to user‐specified levels and a monitoring period of 3 months using SPC facilitated in detecting systematic and random variations. SPC analysis for couch positional accuracy enabled greater control in the identification of errors, thereby increasing confidence levels in daily treatment setups.
Collapse
Affiliation(s)
- Diana Binny
- Department of Radiation Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Queensland, Australia.,Science and Engineering Faculty, Queensland University of Technology, Queensland, Australia
| | - Craig M Lancaster
- Department of Radiation Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Queensland, Australia
| | - Jamie V Trapp
- Science and Engineering Faculty, Queensland University of Technology, Queensland, Australia
| | - Scott B Crowe
- Department of Radiation Oncology, Cancer Care Services, Royal Brisbane and Women's Hospital, Queensland, Australia.,Science and Engineering Faculty, Queensland University of Technology, Queensland, Australia
| |
Collapse
|
8
|
Investigating output and energy variations and their relationship to delivery QA results using Statistical Process Control for helical tomotherapy. Phys Med 2017; 38:105-110. [DOI: 10.1016/j.ejmp.2017.05.052] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2016] [Revised: 05/04/2017] [Accepted: 05/04/2017] [Indexed: 11/19/2022] Open
|
9
|
Moutrie ZR, Lancaster CM, Yu L. First experiences in using a dose control system on a TomoTherapy Hi·Art II. J Appl Clin Med Phys 2015; 16:5489. [PMID: 26103503 PMCID: PMC5690136 DOI: 10.1120/jacmp.v16i3.5489] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Revised: 01/14/2015] [Accepted: 01/07/2015] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to investigate the impact of a dose control system (DCS) servo installed on two fully commissioned TomoTherapy Hi·Art II treatment units. This servo is designed to actively adjust machine parameters to control the output variation of a tomotherapy unit to within ± 0.5% of the nominal dose rate. Machine output, dose rate, and patient-specific quality assurance data were retrospectively analyzed for periods prior to and following the installation of the servo system. Quality assurance tests indicate a reduction in the rotational variation of the output during a procedure, where the peak-to-peak amplitude of the variation was ± 1.30 prior to DCS and equal to ± 0.4 with DCS. Comparing two tomotherapy unit static outputs over four years the percentage error was 1.05% ± 0.7% and -0.4% ± 0.66% and, once DCS was installed, was reduced to -0.22% ± 0.29% and -0.08% ± 0.16%. The results of the quality assurance tests indicate that the dose control system reduced the output variation of each machine for both static and rotational delivery, leading to an improvement in the overall performance of the machine and providing greater certainty in treatment delivery.
Collapse
Affiliation(s)
- Zoë R Moutrie
- Royal Brisbane and Women's Hospital, Herston, QLD, 4029, Australia.
| | | | | |
Collapse
|
10
|
Peng JL, Ashenafi MS, McDonald DG, Vanek KN. Assessment of a three-dimensional (3D) water scanning system for beam commissioning and measurements on a helical tomotherapy unit. J Appl Clin Med Phys 2015; 16:4980. [PMID: 25679156 PMCID: PMC5689986 DOI: 10.1120/jacmp.v16i1.4980] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2014] [Revised: 08/22/2014] [Accepted: 08/21/2014] [Indexed: 11/23/2022] Open
Abstract
Beam scanning data collected on the tomotherapy linear accelerator using the TomoScanner water scanning system is primarily used to verify the golden beam profiles included in all Helical TomoTherapy treatment planning systems (TOMO TPSs). The user is not allowed to modify the beam profiles/parameters for beam modeling within the TOMO TPSs. The authors report the first feasibility study using the Blue Phantom Helix (BPH) as an alternative to the TomoScanner (TS) system. This work establishes a benchmark dataset using BPH for target commissioning and quality assurance (QA), and quantifies systematic uncertainties between TS and BPH. Reproducibility of scanning with BPH was tested by three experienced physicists taking five sets of measurements over a six‐month period. BPH provides several enhancements over TS, including a 3D scanning arm, which is able to acquire necessary beam‐data with one tank setup, a universal chamber mount, and the OmniPro software, which allows online data collection and analysis. Discrepancies between BPH and TS were estimated by acquiring datasets with each tank. In addition, data measured with BPH and TS was compared to the golden TOMO TPS beam data. The total systematic uncertainty, defined as the combination of scanning system and beam modeling uncertainties, was determined through numerical analysis and tabulated. OmniPro was used for all analysis to eliminate uncertainty due to different data processing algorithms. The setup reproducibility of BPH remained within 0.5 mm/0.5%. Comparing BPH, TS, and Golden TPS for PDDs beyond maximum depth, the total systematic uncertainties were within 1.4 mm/2.1%. Between BPH and TPS golden data, maximum differences in the field width and penumbra of in‐plane profiles were within 0.8 and 1.1 mm, respectively. Furthermore, in cross‐plane profiles, the field width differences increased at depth greater than 10 cm up to 2.5 mm, and maximum penumbra uncertainties were 5.6 mm and 4.6 mm from TS scanning system and TPS modeling, respectively. Use of BPH reduced measurement time by 1–2 hrs per session. The BPH has been assessed as an efficient, reproducible, and accurate scanning system capable of providing a reliable benchmark beam data. With this data, a physicist can utilize the BPH in a clinical setting with an understanding of the scan discrepancy that may be encountered while validating the TPS or during routine machine QA. Without the flexibility of modifying the TPS and without a golden beam dataset from the vendor or a TPS model generated from data collected with the BPH, this represents the best solution for current clinical use of the BPH. PACS number: 87.56.Fc
Collapse
|
11
|
Mikołajczyk K, Piotrowski T. Development of cylindrical stepwedge phantom for routine quality controls of a helical tomotherapy machine. Phys Med 2013; 29:91-8. [PMID: 22209626 DOI: 10.1016/j.ejmp.2011.12.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2011] [Revised: 10/25/2011] [Accepted: 12/11/2011] [Indexed: 12/01/2022] Open
Affiliation(s)
- Krzysztof Mikołajczyk
- Department of Medical Physics, Greater Poland Cancer Centre, 15th Garbary Street, 61-866 Poznań, Poland.
| | | |
Collapse
|
12
|
Wooten HO, Goddu SM, Rodriguez V, Cates J, Grigsby P, Low DA. The use of exit detector sinograms to detect anatomical variations for patients extending beyond the TomoTherapy field of view: a feasibility study. Med Phys 2012; 39:6407-19. [PMID: 23039676 DOI: 10.1118/1.4754583] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE This work describes an independent method to use the TomoTherapy Hi-ART megavoltage CT imaging system for daily monitoring of anatomical changes of cancer patients whose anatomy extends beyond the imaging field of view. METHODS The imaging detector response to changes in attenuating media was measured using water-equivalent plastic. Weight loss was simulated using an anthropomorphic phantom and determining the system's ability to detect the weight loss. Layers of tissue-equivalent bolus were added to an anthropomorphic pelvis phantom and CT simulations of the phantom were conducted, one in which the phantom and bolus were both within the TomoTherapy imaging field of view, and another in which the couch was raised so that the bolus was outside the field of view. Gynecological treatment plans were developed using the TomoTherapy treatment planning system, and successive fractions of the plan were then delivered to the phantom. Weight loss was simulated by removing a 0.5 cm layer of bolus following each fraction. The exit detector sinograms were obtained from each fraction, and ratios of sinograms were calculated relative to a reference sinogram for which all bolus was in place. Histograms of ratio sinograms were determined and used to correlate with simulated weight loss. Exit detector sinograms and ratio histograms were also retrospectively analyzed for five patients all of whose anatomies extended beyond the imaging field of view and all of whom experienced weight variations exceeding 10% during treatment. RESULTS Exit detector signal is well correlated to changes in attenuator thickness as demonstrated in both slab and anthropomorphic phantom geometries. Measured and expected signal increases agreed to within less than 2% for simulated weight loss on the anthropomorphic phantom. Exit detector signals for pelvic patients with significant weight loss variations were consistent with phantom measurements. CONCLUSIONS The analysis of the ratio sinograms for the phantom measurements and real patients indicated that exit detector sinograms can be used to detect relative changes in patient anatomy for each fraction as a means of in vivo quality assurance.
Collapse
Affiliation(s)
- H Omar Wooten
- Department of Radiation Oncology, Washington University, Saint Louis, MO, USA.
| | | | | | | | | | | |
Collapse
|
13
|
Pavoni JF, Pike TL, Snow J, DeWerd L, Baffa O. Tomotherapy dose distribution verification using MAGIC-fpolymer gel dosimetry. Med Phys 2012; 39:2877-84. [DOI: 10.1118/1.4704496] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
|
14
|
Depuydt T, Penne R, Verellen D, Hrbacek J, Lang S, Leysen K, Vandevondel I, Poels K, Reynders T, Gevaert T, Duchateau M, Tournel K, Boussaer M, Cosentino D, Garibaldi C, Solberg T, Ridder MD. Computer-aided analysis of star shot films for high-accuracy radiation therapy treatment units. Phys Med Biol 2012; 57:2997-3011. [DOI: 10.1088/0031-9155/57/10/2997] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
15
|
Althof V, van Haaren P, Westendorp R, Nuver T, Kramer D, Ikink M, Bel A, Minken A. A quality assurance tool for helical tomotherapy using a step-wedge phantom and the on-board MVCT detector. J Appl Clin Med Phys 2012; 13:3585. [PMID: 22231210 PMCID: PMC5716125 DOI: 10.1120/jacmp.v13i1.3585] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2011] [Revised: 08/25/2011] [Accepted: 08/19/2011] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to develop and evaluate filmless quality assurance (QA) tools for helical tomotherapy by using the signals from the on-board megavoltage computed tomography (MVCT) detector and applying a dedicated step-wedge phantom. The step-wedge phantom is a 15 cm long step-like aluminum block positioned on the couch. The phantom was moved through the slit beam and MVCT detector signals were analyzed. Two QA procedures were developed, with gantry fixed at 0°: 1) step-wedge procedure: to check beam energy consistency, field width, laser alignment with respect to the virtual isocenter, couch movement, and couch velocity; and 2) completion procedure: to check the accuracy of a field abutment made by the tomotherapy system after a treatment interruption. The procedures were designed as constancy tool and were validated by measurement of deliberately induced variations and comparison with a reference method. Two Hi-Art II machines were monitored over a period of three years using the step-wedge procedures. The data acquisition takes 5 minutes. The analysis is fully automated and results are available directly after acquisition. Couch speed deviations up to 2% were induced. The mean absolute difference between expected and measured couch speed was 0.2% ± 0.2% (1 standard deviation SD). Field width was varied around the 10 mm nominal size, between 9.7 and 11.1 mm, in steps of 0.2 mm. Mean difference between the step-wedge analysis and the reference method was < 0.01 mm ± 0.03 mm (1 SD). Laser (mis)alignment relative to a reference situation was detected with 0.3 mm precision (1SD). The step-wedge profile was fitted to a PDD in water. The PDD ratio D20/D10, measured at depths of 20 cm and 10 cm, was used to check beam energy consistency. Beam energy variations were induced. Mean difference between step-wedge and water PDD ratios was 0.2% ± 0.3% (1SD). The completion procedure was able to reveal abutment mismatches with a mean error of -0.6 mm ± 0.2 mm (1SD). The trending data over a period of three years showed a mean deviation of 0.4% ± 0.1% (1 SD) in couch speed. The spread in field width was 0.15 mm (1 SD). The sagittal and transverse lasers showed a variation of 0.5 mm (1 SD). Beam energy varied 1.0% (1 SD). A mean abutment mismatch was found of -0.4 mm ± 0.2 mm (1 SD) between interrupted treatments. The on-board MVCT detector, in combination with the step-wedge phantom, is a suitable tool for a QA program for helical tomotherapy. The method allowed frequent monitoring of machine behavior for the past three years.
Collapse
Affiliation(s)
- Vincent Althof
- Radiotherapeutic Institute RISO, Deventer, The Netherlands.
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Wong JHD, Hardcastle N, Tomé WA, Bayliss A, Tolakanahalli R, Lerch MLF, Petasecca M, Carolan M, Metcalfe P, Rosenfeld AB. Independent quality assurance of a helical tomotherapy machine using the dose magnifying glass. Med Phys 2011; 38:2256-64. [PMID: 21626960 DOI: 10.1118/1.3566067] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE Helical tomotherapy is a complex delivery technique, integrating CT image guidance and intensity modulated radiotherapy in a single system. The integration of the CT detector ring on the gantry not only allows patient position verification but is also often used to perform various QA procedures. This convenience lacks the rigor of a machine-independent QA process. METHODS In this article, a Si strip detector, known as the Dose Magnifying Glass (DMG), was used to perform machine-independent QA measurements of the multileaf collimator alignment, leaf open time threshold, and leaf fluence output factor (LFOF). RESULTS The DMG measurements showed good agreements with EDR2 film for the MLC alignment test while the CT detector agrees well with DMG measurements for leaf open time threshold and LFOF measurements. The leaf open time threshold was found to be approximately 20 ms. The LFOF measured with the DMG agreed within error with the CT detector measured LFOF. CONCLUSIONS The DMG with its 0.2 mm spatial resolution coupled to TERA ASIC allowed real-time high temporal resolution measurements of the tomotherapy leaf movement. In conclusion, DMG was shown to be a suitable tool for machine-independent QA of a tomotherapy unit.
Collapse
Affiliation(s)
- J H D Wong
- Centre for Medical Radiation Physics, University of Wollongong, New South Wales 2522, Australia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Hundertmark B, Sterpin E, Mackie T. A robust procedure for verifying TomoTherapy Hi-Art™ source models for small fields. Phys Med Biol 2011; 56:3685-99. [DOI: 10.1088/0031-9155/56/12/015] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
18
|
Sharma M, Dos Santos T, Papanikolopoulos NP, Hui SK. Feasibility of intrafraction whole-body motion tracking for total marrow irradiation. JOURNAL OF BIOMEDICAL OPTICS 2011; 16:058002. [PMID: 21639586 PMCID: PMC3113335 DOI: 10.1117/1.3575645] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2010] [Revised: 03/11/2011] [Accepted: 03/21/2011] [Indexed: 05/30/2023]
Abstract
With image-guided tomotherapy, highly targeted total marrow irradiation (TMI) has become a feasible alternative to conventional total body irradiation. The uncertainties in patient localization and intrafraction motion of the whole body during hour-long TMI treatment may pose a risk to the safety and accuracy of targeted radiation treatment. The feasibility of near-infrared markers and optical tracking system (OTS) is accessed along with a megavoltage scanning system of tomotherapy. Three near-infrared markers placed on the face of a rando phantom are used to evaluate the capability of OTS in measuring changes in the markers' positions as the rando is moved in the translational direction. The OTS is also employed to determine breathing motion related changes in the position of 16 markers placed on the chest surface of human volunteers. The maximum uncertainty in locating marker position with the OTS is 1.5 mm. In the case of normal and deep breathing motion, the maximum marker position change is observed in anterior-posterior direction with the respective values of 4 and 12 mm. The OTS is able to measure surface changes due to breathing motion. The OTS may be optimized to monitor whole body motion during TMI to increase the accuracy of treatment delivery and reduce the radiation dose to the lungs.
Collapse
Affiliation(s)
- Manju Sharma
- Department of Therapeutic Radiology-Radiation Oncology,University of Minnesota Medical School, MMC 494-420 Delaware Street SE, Minneapolis, Minnesota 55455, USA
| | | | | | | |
Collapse
|
19
|
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood 2010; 117:309-15. [PMID: 20876852 DOI: 10.1182/blood-2010-06-288357] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
This phase 1/2 study assessed the augmentation of reduced-intensity conditioning (RIC) with total marrow and lymph node irradiation (TMLI), for peripheral blood stem cell transplantation, in patients with advanced hematologic disease. The regimen consisted of fludarabine 25 mg/m(2) per day for 5 days, melphalan 140 mg/m(2) for one day, and TMLI radiation at 150 cGy/fraction in 8 fractions over 4 days. Eligible patients were over 50 years old and/or had compromised organ function. Median age of the 33 evaluable patients was 55.2 years. Eighteen events of nonhematologic grade III or higher toxicities occurred in 9 patients. Day 30 and day 100 mortalities were 3% and 15%, respectively. Patients achieved myeloid and platelet engraftment at a median of 14 days after transplantation. Long-term toxicities occurred in 2 patients: hypokalemia and tremor, both grade III, on days 370 and 361 after transplantation. Fourteen patients died, 7 of relapse-related causes and 7 of non-relapse-related causes. With a median follow-up for living patients of 14.7 months, 1-year overall survival, event-free survival, and non-relapse-related mortality were 75%, 65%, and 19%, respectively. Addition of TMLI to RIC is feasible and safe and could be offered to patients with advanced hematologic malignancies who might not otherwise be candidates for RIC.
Collapse
|
20
|
Langen KM, Papanikolaou N, Balog J, Crilly R, Followill D, Goddu SM, Grant W, Olivera G, Ramsey CR, Shi C. QA for helical tomotherapy: Report of the AAPM Task Group 148a). Med Phys 2010; 37:4817-53. [DOI: 10.1118/1.3462971] [Citation(s) in RCA: 179] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
|
21
|
Kinhikar RA, Jamema SV, Reenadevi, Pai R, Zubin M, Gupta T, Dhote DS, Deshpande DD, Shrivastava SK, Sarin R. Dosimetric validation of first helical tomotherapy Hi-Art II machine in India. J Med Phys 2010; 34:23-30. [PMID: 20126562 PMCID: PMC2804144 DOI: 10.4103/0971-6203.48717] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2008] [Accepted: 01/05/2009] [Indexed: 11/27/2022] Open
Abstract
A Helical Tomotherapy (HT) Hi-Art II machine, Hi ART (TomoTherapy, Inc., Madison, WI, USA) was installed at our center in July 2007, and was the first machine in India. Image-guided HT is a new modality for delivering intensity modulated radiotherapy (IMRT). Dosimetric tests done include (a) primary beam alignment (b) secondary beam alignment (c) water tank measurements (profiles and depth doses) (d) dose rate measurements (e) IMRT verification, and (f) Mega voltage Computed Tomography (MVCT) dose. Primary and secondary beam alignment revealed an acceptable linear accelerator (linac) alignment in both X and Y axes. In addition, it was observed that the beam was aligned in the same plane as gantry and the jaws were not twisted with respect to gantry. The rotational beam stability was acceptable. Multi-leaf collimators (MLC) were found to be stable and properly aligned with the radiation plane. The jaw alignment during gantry rotation was satisfactory. Transverse and longitudinal profiles were in good agreement with the “Gold” standard. During IMRT verification, the variation between the measured and calculated dose for a particular plan at the central and off-axis was found to be within 2% and 1mm in position, respectively. The dose delivered during the TomoImage scan was found to be 2.57 cGy. The Helical Tomotherapy system is mechanically stable and found to be acceptable for clinical treatment. It is recommended that the output of the machine should be measured on a daily basis to monitor the fluctuations in output.
Collapse
Affiliation(s)
- Rajesh A Kinhikar
- Department of Medical Physics, Tata Memorial Hospital, Parel, Mumbai, Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Kinhikar RA, Master Z, Dhote DS, Deshpande DD. Initial dosimetric experience with mega voltage computed tomography detectors and estimation of pre and post-repair dosimetric parameters of a first Helical Hi-Art II tomotherapy machine in India. J Med Phys 2010; 34:73-9. [PMID: 20098540 PMCID: PMC2805893 DOI: 10.4103/0971-6203.51933] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2009] [Revised: 03/12/2009] [Accepted: 04/02/2009] [Indexed: 11/28/2022] Open
Abstract
A Helical Tomotherapy™ (HT) Hi-Art II (TomoTherapy, Inc., Madison, WI, USA) has been one of the important innovations to help deliver IMRT with image guidance. On-board, mega voltage computed tomography (MVCT) detectors are used for imaging and dosimetric purpose. The two objectives of this study are: (i) To estimate the dosimetric and general capability (TomoImage registration, reconstruction, contrast and spatial resolution, artifacts-free image and dose in TomoImage) of on-board MVCT detectors. (ii) To measure the dosimetric parameters (output and energy) following major repair. The MVCT detectors also estimated the rotational output constancy well. During this study, dosimetric tests were repeated after replacing MVCT detectors and the target. fixed-gantry/fixed-couch measurements were measured daily to investigate; the system stability. Thermoluminescense dosimeter (TLD) was used during both the measurements subsequently. The MVCT image quality with old and new detectors was comparable and hence acceptable clinically. The spatial resolution was optimal and the dose during TomoImage was 2 cGy (well within the manufacturer tolerance of 4 cGy). The results of lateral beam profiles showed an excellent agreement between the two normalized plots. The output from the rotational procedure revealed 99.7% while the energy was consistent over a period of twelve months. The Hi-Art II system has maintained its calibration to within +/− 2% and energy to within +/− 1.5% over the initial twelve-month period. Based on the periodic measurements for rotational output and consistency in the lateral beam profile shape, the on-board detector proved to be a viable dosimetric quality assurance tool for IMRT with Tomotherapy. Tomotherapy was stable from the dosimetric point of view during the twelve-month period.
Collapse
Affiliation(s)
- Rajesh A Kinhikar
- Department of Medical Physics, Tata Memorial Centre, Parel, Mumbai 400012, India
| | | | | | | |
Collapse
|
23
|
Sen A, West MK. Commissioning experience and quality assurance of helical tomotherapy machines. J Med Phys 2010; 34:194-9. [PMID: 20098548 PMCID: PMC2807140 DOI: 10.4103/0971-6203.56078] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2008] [Revised: 03/18/2009] [Accepted: 03/19/2009] [Indexed: 11/23/2022] Open
Abstract
A helical tomotherapy machine combines a straight 6 MV linear accelerator mounted on a ring gantry with CT technology for image-guided intensity-modulated radiation therapy (IMRT) treatment. A fan beam created by the collimator and jaws produces a maximum of 40 × 5 cm2 field size at the isocenter. The gantry and hence the fan beam rotates at a constant speed while the couch moves linearly into the gantry bore, thus producing a helical delivery. The beam is modulated by a 64-leaf binary multileaf collimator (MLC), which enables IMRT treatment. The linac can be operated at a lower voltage (3.5 MV) and dose rate to produce megavoltage CT images, which are used for image-guided patient setup. We have installed two such units since 2004 and treated more than 2000 patients. The machine comes “precommissioned” from the manufacturer, and the beam characteristics and IMRT plans on phantom are measured and compared with manufacturer's data after acceptance tests are performed on site. Our experience with commissioning the machines and periodic quality assurance with tolerance limits for optimal performance are described.
Collapse
Affiliation(s)
- Amarjit Sen
- Department of Radiation Oncology, Cancer Treatment Centers of America, Tulsa, OK 74133, USA
| | | |
Collapse
|
24
|
Kim B, Chen J, Kron T, Battista J. Motion-induced dose artifacts in helical tomotherapy. Phys Med Biol 2009; 54:5707-34. [PMID: 19729710 DOI: 10.1088/0031-9155/54/19/004] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
|
25
|
Goddu SM, Mutic S, Pechenaya OL, Chaudhari SR, Garcia-Ramirez J, Rangaraj D, Klein EE, Yang D, Grigsby J, Low DA. Enhanced efficiency in helical tomotherapy quality assurance using a custom-designed water-equivalent phantom. Phys Med Biol 2009; 54:5663-74. [DOI: 10.1088/0031-9155/54/19/001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
26
|
Francois P, Mazal A. Static and rotational output variation of a tomotherapy unit. Med Phys 2009; 36:816-20. [DOI: 10.1118/1.3075898] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Balog J, Soisson E. Helical tomotherapy quality assurance. Int J Radiat Oncol Biol Phys 2008; 71:S113-7. [PMID: 18406907 DOI: 10.1016/j.ijrobp.2007.10.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2007] [Revised: 09/13/2007] [Accepted: 10/02/2007] [Indexed: 11/16/2022]
Abstract
Helical tomotherapy uses a dynamic delivery in which the gantry, treatment couch, and multileaf collimator leaves are all in motion during treatment. This results in highly conformal radiotherapy, but the complexity of the delivery is partially hidden from the end-user because of the extensive integration and automation of the tomotherapy control systems. This presents a challenge to the medical physicist who is expected to be both a system user and an expert, capable of verifying relevant aspects of treatment delivery. A related issue is that a clinical tomotherapy planning system arrives at a customer's site already commissioned by the manufacturer, not by the clinical physicist. The clinical physicist and the manufacturer's representative verify the commissioning at the customer site before acceptance. Theoretically, treatment could begin immediately after acceptance. However, the clinical physicist is responsible for the safe and proper use of the machine. In addition, the therapists and radiation oncologists need to understand the important machine characteristics before treatment can proceed. Typically, treatment begins about 2 weeks after acceptance. This report presents an overview of the tomotherapy system. Helical tomotherapy has unique dosimetry characteristics, and some of those features are emphasized. The integrated treatment planning, delivery, and patient-plan quality assurance process is described. A quality assurance protocol is proposed, with an emphasis on what a clinical medical physicist could and should check. Additionally, aspects of a tomotherapy quality assurance program that could be checked automatically and remotely because of its inherent imaging system and integrated database are discussed.
Collapse
Affiliation(s)
- John Balog
- Department of Radiation Oncology, Mohawk Valley Medical Physics, Rome, NY 13440, USA.
| | | |
Collapse
|
28
|
Patient specific dosimetry for intensity-modulated radiotherapy delivered with first helical tomotherapy in India — our initial experience of 50 patients. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE 2008; 31:139-45. [DOI: 10.1007/bf03178588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
29
|
Hsiao Y, Stewart RD, Li XA. A Monte-Carlo derived dual-source model for helical tomotherapy treatment planning. Technol Cancer Res Treat 2008; 7:141-7. [PMID: 18345703 DOI: 10.1177/153303460800700207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Full Monte Carlo radiation transport simulations of accelerator heads are impractical for routine treatment planning because of the excessive computational burden and memory requirements. To improve the accuracy and efficiency of treatment plans for helical tomotherapy, we have developed a dual-source model to characterize the radiation emitted from the head of a commercial helical tomotherapy accelerator. Percentage depth dose (PDD) and beam profiles computed using the dual-source model with the EGS/BEAMnrc Monte Carlo package agree within 2% of measurements for a wide range of field sizes, which suggests that the proposed dual-source model provides an adequate representation of the tomotherapy head for dose calculations in routine treatment planning.
Collapse
Affiliation(s)
- Yayun Hsiao
- Department of Physics, Purdue University, West Lafayette, IN 47907-2036, USA
| | | | | |
Collapse
|
30
|
Broggi S, Mauro Cattaneo G, Molinelli S, Maggiulli E, Del Vecchio A, Longobardi B, Perna L, Fazio F, Calandrino R. Results of a two-year quality control program for a helical tomotherapy unit. Radiother Oncol 2008; 86:231-41. [DOI: 10.1016/j.radonc.2007.11.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2007] [Revised: 10/31/2007] [Accepted: 11/02/2007] [Indexed: 10/22/2022]
|
31
|
Joshi CP, Darko J, Vidyasagar PB, Schreiner LJ. Investigation of an efficient source design for Cobalt-60-based tomotherapy using EGSnrc Monte Carlo simulations. Phys Med Biol 2008; 53:575-92. [DOI: 10.1088/0031-9155/53/3/005] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
32
|
Detorie NA. Helical Tomotherapy: A New Tool for Radiation Therapy. J Am Coll Radiol 2008; 5:63-6. [DOI: 10.1016/j.jacr.2007.09.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2007] [Indexed: 11/17/2022]
|
33
|
Chen YJ, Liu A, Han C, Tsai PT, Schultheiss TE, Pezner RD, Vora N, Lim D, Shibata S, Kernstine KH, Wong JYC. Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim 2007; 32:166-71. [PMID: 17707195 DOI: 10.1016/j.meddos.2006.12.003] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2006] [Accepted: 12/14/2006] [Indexed: 11/19/2022]
Abstract
We compare different radiotherapy techniques-helical tomotherapy (tomotherapy), step-and-shoot IMRT (IMRT), and 3-dimensional conformal radiotherapy (3DCRT)-for patients with mid-distal esophageal carcinoma on the basis of dosimetric analysis. Six patients with locally advanced mid-distal esophageal carcinoma were treated with neoadjuvant chemoradiation followed by surgery. Radiotherapy included 50 Gy to gross planning target volume (PTV) and 45 Gy to elective PTV in 25 fractions. Tomotherapy, IMRT, and 3DCRT plans were generated. Dose-volume histograms (DVHs), homogeneity index (HI), volumes of lung receiving more than 10, 15, or 20 Gy (V(10), V(15), V(20)), and volumes of heart receiving more than 30 or 45 Gy (V(30), V(45)) were determined. Statistical analysis was performed by paired t-tests. By isodose distributions and DVHs, tomotherapy plans showed sharper dose gradients, more conformal coverage, and better HI for both gross and elective PTVs compared with IMRT or 3DCRT plans. Mean V(20) of lung was significantly reduced in tomotherapy plans. However, tomotherapy and IMRT plans resulted in larger V(10) of lung compared to 3DCRT plans. The heart was significantly spared in tomotherapy and IMRT plans compared to 3DCRT plans in terms of V(30) and V(45). We conclude that tomotherapy plans are superior in terms of target conformity, dose homogeneity, and V(20) of lung.
Collapse
Affiliation(s)
- Yi-Jen Chen
- Internal Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Qi XS, Schultz CJ, Li XA. Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations. Phys Med Biol 2007; 52:5667-82. [PMID: 17804888 DOI: 10.1088/0031-9155/52/18/013] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The aim of this study was to estimate a plausible alpha/beta ratio for arteriovenous malformations (AVMs) based on reported clinical data, and to design possible fractionation regimens suitable for image-guided intensity-modulated radiation therapy (IG-IMRT) for large AVMs based on the newly obtained alpha/beta ratio. The commonly used obliteration rate (OR) for AVMs with a three year angiographic follow-up from many institutes was fitted to linear-quadratic (LQ) formalism and the Poisson OR model. The determined parameters were then used to calculate possible fractionation regimens for IG-IMRT based on the concept of a biologically effective dose (BED) and an equivalent uniform dose (EUD). The radiobiological analysis yields a alpha/beta ratio of 2.2 +/- 1.6 Gy for AVMs. Three sets of possible fractionated schemes were designed to achieve equal or better biological effectiveness than the single-fraction treatments while maintaining the same probability of normal brain complications. A plausible alpha/beta ratio was derived for AVMs and possible fractionation regimens that may be suitable for IG-IMRT for large AVM treatment are proposed. The sensitivity of parameters on the calculation was also studied. The information may be useful to design new clinical trials that use IG-IMRT for the treatment of large AVMs.
Collapse
Affiliation(s)
- X Sharon Qi
- Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
| | | | | |
Collapse
|
35
|
Sarkar V, Lin L, Shi C, Papanikolaou N. Quality assurance of the multileaf collimator with helical tomotherapy: Design and implementation. Med Phys 2007; 34:2949-56. [PMID: 17822003 DOI: 10.1118/1.2748105] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Quality assurance (QA) of the multileaf collimator (MLC) is a critical step for the delivery of intensity modulated radiation therapy treatment plan. While QA procedures for motor-driven MLC have been published extensively, those for binary MLCs such as the one used for helical tomotherapy have not been presented in the literature, as this is still a fairly new technology. In this study, seven test patterns for the MLC QA of a helical tomotherapy unit have been designed and implemented. The seven test patterns check the MLC alignment, MLC leakage, MLC timing and MLC leaf position error in detail. Those patterns can be easily implemented in any center with a helical tomotherapy unit as part of the routine QA. The QA procedures can be performed using existing QA resources such as solid water phantom and EDR2 film. A software toolkit called "Tomo MLC QA" has been developed to assist in generating the QA procedures and analyzing the results. Our results showed that the helical tomotherapy MLC is very robust, exhibiting interleaf leakage of 0.53% +/-0.09%. Several issues with the MLC have been found and discussed. The QA results also illustrate the utilization and usefulness of the proposed QA procedures.
Collapse
Affiliation(s)
- Vikren Sarkar
- University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
| | | | | | | |
Collapse
|
36
|
Fenwick JD, Tomé WA, Soisson ET, Mehta MP, Rock Mackie T. Tomotherapy and other innovative IMRT delivery systems. Semin Radiat Oncol 2007; 16:199-208. [PMID: 17010902 DOI: 10.1016/j.semradonc.2006.04.002] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Fixed-field treatments, delivered using conventional clinical linear accelerators fitted with multileaf collimators, have rapidly become the standard form of intensity-modulated radiotherapy (IMRT). Several innovative nonstandard alternatives also exist, for which delivery and treatment planning systems are now commercially available. Three of these nonstandard IMRT approaches are reviewed here: tomotherapy, robotic linear accelerators (CyberKnife, Accuray Inc., Sunnyvale, CA), and standard linear accelerators modulated by jaws alone or by their jaws acting together with a tertiary beam-masking device. Rationales for the nonstandard IMRT approaches are discussed, and elements of their delivery system designs are briefly described. Differences between fixed-field IMRT dose distributions and the distributions that can be delivered by using the nonstandard technologies are outlined. Because conventional linear accelerators are finely honed machines, innovative design enhancement of one aspect of system performance often limits another facet of machine capability. Consequently the various delivery systems may prove optimal for different types of treatment, with specific machine designs excelling for disease sites with specific target volume and normal structure topologies. However it is likely that the delivery systems will be distinguished not just by the optimality of the dose distributions they deliver, but also by factors such as the efficiency of their treatment process, the integration of their onboard imaging systems into that process, and their ability to measure and minimize or compensate for target movement, including the effects of respiratory motion.
Collapse
Affiliation(s)
- John D Fenwick
- Department of Medical Physics, Clatterbridge Centre for Oncology, Wirral, United Kingdom.
| | | | | | | | | |
Collapse
|
37
|
Tomotherapy as a tool in image-guided radiation therapy (IGRT): theoretical and technological aspects. Biomed Imaging Interv J 2007; 3:e16. [PMID: 21614257 PMCID: PMC3097641 DOI: 10.2349/biij.3.1.e16] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2006] [Accepted: 01/30/2007] [Indexed: 11/29/2022] Open
Abstract
Helical tomotherapy (HT) is a novel treatment approach that combines Intensity-Modulate Radiation Therapy (IMRT) delivery with in-built image guidance using megavoltage (MV) CT scanning. The technique utilises a 6 MV linear accelerator mounted on a CT type ring gantry. The beam is collimated to a fan beam, which is intensity modulated using a binary multileaf collimator (MLC). As the patient advances slowly through the ring gantry, the linac rotates around the patient with a leaf-opening pattern optimised to deliver a highly conformal dose distribution to the target in the helical beam trajectory. The unit also allows the acquisition of MVCT images using the same radiation source detuned to reduce its effective energy to 3.5 MV, making the dose required for imaging less than 3 cGy. This paper discusses the major features of HT and describes the advantages and disadvantages of this approach in the context of the commercial Hi-ART system.
Collapse
|
38
|
Abstract
A multifaceted tomotherapy quality assurance procedure has been developed. This procedure tests most of the features inherent in the tomotherapy Hi-Art device. This includes the megavoltage imaging quality, spatial and temporal accuracy of the dynamic delivery properties, as well as more traditional beam output characteristics. This is accomplished with a specialized multichannel electrometer that measures collected charge every 100 ms and a Virtual Water cylindrical phantom that holds many ion chambers and differing density insert plugs. Both devices are offered with the Hi-Art product. These tests are presented as well as their sensitivity to beam and delivery variations.
Collapse
Affiliation(s)
- John Balog
- Mohawk Valley Medical Physics, Rome, New York 13440, USA
| | | | | |
Collapse
|
39
|
Balog J, Lucas D, DeSouza C, Crilly R. Helical tomotherapy radiation leakage and shielding considerations. Med Phys 2005; 32:710-9. [PMID: 15839342 DOI: 10.1118/1.1861521] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Leakage radiation and room shielding considerations increase significantly for intensity-modulated radiation therapy (IMRT) treatments due to the increased beam-on time to deliver modulated fields. Tomotherapy, with its slice by slice approach to IMRT, further exacerbates this increase. Accordingly, additional shielding is used in tomotherapy machines to reduce unwanted radiation. The competing effects of the high modulation and the enhanced shielding were studied. The overall room leakage radiation levels are presented for the continuous gantry rotations, which are always used during treatments. The measured leakage at 4 m from the isocenter is less than 3 x 10(-4) relative to calibration output. Primary radiation exposure levels were investigated as well. The effect of forward-directed leakage through the beam-collimation system was studied, as this is the leakage dose the patient would receive in the course of a treatment. A 12-min treatment was calculated to produce only 1% patient leakage dose to the periphery region. Longer treatment times might yield less patient dose if the field width selected is correspondingly narrower. A method for estimating the worst-case leakage dose a patient would receive is presented.
Collapse
Affiliation(s)
- John Balog
- TomoTherapy Incorporated, 1240 Deming Way, Madison, WI 53717, USA.
| | | | | | | |
Collapse
|
40
|
Yan Y, Papanikolaou N, Weng X, Penagaricano J, Ratanatharathorn V. Fast radiographic film calibration procedure for helical tomotherapy intensity modulated radiation therapy dose verification. Med Phys 2005; 32:1566-70. [PMID: 16013715 DOI: 10.1118/1.1924327] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Film dosimetry offers an advantageous in-phantom planar dose verification tool in terms of spatial resolution and ease of handling for quality assurance (QA) of intensity modulated radiation therapy (IMRT) plans. A critical step in the success of such a technique is that the film calibration be appropriately conducted. This paper presents a fast and efficient film calibration method for a helical tomotherapy unit using a single sheet of film. Considering the unique un-flattened cone shaped profile from a helical tomotherapy beam, a custom leaf control file (sinogram) was created, to produce a valley shaped intensity pattern. There are eleven intensity steps in the valley pattern, representing varying dose values from 38 to 265 cGy. This dose range covers the most commonly prescribed doses in fractionated IMRT treatments. An ion chamber in a solid water phantom was used to measure the dose in each of the eleven steps. For daily film calibration the whole procedure, including film exposure, processing, digitization and analysis, can be completed within 15 min, making it practical to use this technique routinely. This method is applicable to film calibration on a helical tomotherapy unit and is particularly useful in IMRT planar dose verification due to its efficiency and reproducibility. In this work, we characterized the dose response of the KODAK EDR2 ready-pack film which was used to develop the step valley dose maps and the IMRT QA planar doses. A comparison between the step valley technique and multifilm based calibration showed that both calibration methods agreed with less than 0.4% deviation in the clinically useful dose ranges.
Collapse
Affiliation(s)
- Yulong Yan
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199, USA.
| | | | | | | | | |
Collapse
|
41
|
Fenwick JD, Tomé WA, Jaradat HA, Hui SK, James JA, Balog JP, DeSouza CN, Lucas DB, Olivera GH, Mackie TR, Paliwal BR. Quality assurance of a helical tomotherapy machine. Phys Med Biol 2005; 49:2933-53. [PMID: 15285257 DOI: 10.1088/0031-9155/49/13/012] [Citation(s) in RCA: 93] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Helical tomotherapy has been developed at the University of Wisconsin, and 'Hi-Art II' clinical machines are now commercially manufactured. At the core of each machine lies a ring-gantry-mounted short linear accelerator which generates x-rays that are collimated into a fan beam of intensity-modulated radiation by a binary multileaf, the modulation being variable with gantry angle. Patients are treated lying on a couch which is translated continuously through the bore of the machine as the gantry rotates. Highly conformal dose-distributions can be delivered using this technique, which is the therapy equivalent of spiral computed tomography. The approach requires synchrony of gantry rotation, couch translation, accelerator pulsing and the opening and closing of the leaves of the binary multileaf collimator used to modulate the radiation beam. In the course of clinically implementing helical tomotherapy, we have developed a quality assurance (QA) system for our machine. The system is analogous to that recommended for conventional clinical linear accelerator QA by AAPM Task Group 40 but contains some novel components, reflecting differences between the Hi-Art devices and conventional clinical accelerators. Here the design and dosimetric characteristics of Hi-Art machines are summarized and the QA system is set out along with experimental details of its implementation. Connections between this machine-based QA work, pre-treatment patient-specific delivery QA and fraction-by-fraction dose verification are discussed.
Collapse
Affiliation(s)
- J D Fenwick
- Department of Human Oncology, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Mahan SL, Chase DJ, Ramsey CR. Technical note: output and energy fluctuations of the tomotherapy Hi-Art helical tomotherapy system. Med Phys 2005; 31:2119-20. [PMID: 15305465 DOI: 10.1118/1.1763007] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The output and energy calibrations for the first clinical Hi-Art 2.0 helical tomotherapy system have been reviewed. Fixed-gantry/fixed-couch and rotational-gantry/fixed-couch measurements were made on a daily basis over a period of 20 weeks to investigate system stability. Static gantry measurements were taken at 10 cm depth in a rectangular stack of Virtual Water at an SSD distance of 90 cm and a field size of 5 x 40 cm. Rotational gantry measurements were taken in a cylindrical phantom Virtual Water phantom for a field size of 5 x 40 cm. The Hi-Art 2.0 system has maintained its calibration to within +/-2% and energy to within +/- 1.5% over the initial 20 week period.
Collapse
Affiliation(s)
- Stephen L Mahan
- Thompson Cancer Survival Center, Knoxville, Tennessee 37916, USA.
| | | | | |
Collapse
|
43
|
Boudou C, Biston MC, Corde S, Adam JF, Ferrero C, Estève F, Elleaume H. Synchrotron stereotactic radiotherapy: dosimetry by Fricke gel and Monte Carlo simulations. Phys Med Biol 2004; 49:5135-44. [PMID: 15609563 DOI: 10.1088/0031-9155/49/22/008] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Synchrotron stereotactic radiotherapy (SSR) consists in loading the tumour with a high atomic number element (Z), and exposing it to monochromatic x-rays from a synchrotron source (50-100 keV), in stereotactic conditions. The dose distribution results from both the stereotactic monochromatic x-ray irradiation and the presence of the high Z element. The purpose of this preliminary study was to evaluate the two-dimensional dose distribution resulting solely from the irradiation geometry, using Monte Carlo simulations and a Fricke gel dosimeter. The verification of a Monte Carlo-based dosimetry was first assessed by depth dose measurements in a water tank. We thereafter used a Fricke dosimeter to compare Monte Carlo simulations with dose measurements. The Fricke dosimeter is a solution containing ferrous ions which are oxidized to ferric ions under ionizing radiation, proportionally to the absorbed dose. A cylindrical phantom filled with Fricke gel was irradiated in stereotactic conditions over several slices with a continuous beam (beam section = 0.1 x 1 cm2). The phantom and calibration vessels were then imaged by nuclear magnetic resonance. The measured doses were fairly consistent with those predicted by Monte Carlo simulations. However, the measured maximum absolute dose was 10% underestimated regarding calculation. The loss of information in the higher region of dose is explained by the diffusion of ferric ions. Monte Carlo simulation is the most accurate tool for dosimetry including complex geometries made of heterogeneous materials. Although the technique requires improvements, gel dosimetry remains an essential tool for the experimental verification of dose distribution in SSR with millimetre precision.
Collapse
Affiliation(s)
- Caroline Boudou
- INSERM-U647 Rayonnement synchrotron et recherche médicale and ID17 biomedical beamline of the European Synchrotron Radiation Facility, Grenoble, France
| | | | | | | | | | | | | |
Collapse
|
44
|
Abstract
Helical tomotherapy presented many unique dosimetric challenges and solutions during the initial commissioning process, and some of them are presented. The dose calculation algorithm is convolution/superposition based. This requires that the energy fluence spectrum and magnitude be quantified. The methodology for doing so is described. Aspects of the energy fluence characterization that are unique to tomotherapy are highlighted. Many beam characteristics can be measured automatically by an included megavoltage computed tomography imaging system. This greatly improves data collection efficiency.
Collapse
Affiliation(s)
- John Balog
- TomoTherapy Incorporated, Madison, Wisconsin 53717, USA
| | | | | |
Collapse
|